SCHEMBL8310470

SCHEMBL8310470

O=C1NC(=S)S/C1=C\c1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.72
NAT1 P18440 6/20 0.69
MEN1 O00255 1/20 0.69
NPC1 O15118 1/20 0.69
ALDH1A1 P00352 1/20 0.69
LMNA P02545 1/20 0.69
POLB P06746 1/20 0.69
GAA P10253 1/20 0.69
MAPT P10636 1/20 0.69
KMT2A Q03164 1/20 0.69
CRHBP P24387 2/20 0.68
CRHR2 Q13324 2/20 0.68
PLA2G1B P04054 1/20 0.68
ATG4B Q9Y4P1 1/20 0.68
CISD1 Q9NZ45 3/20 0.64
PTGS2 P35354 1/20 0.64
MYC P01106 2/20 0.61
MAX P61244 2/20 0.61
PIK3CG P48736 1/20 0.59
CA2 P00918 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12961160 1.00 DNM1 (0.72) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL8310474 1.00 DNM1 (0.72) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL14586391 0.87 CISD1 (0.83) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL15421930 0.83 PIK3CG (0.76) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL15421931 0.83 PIK3CG (0.76) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL15421927 0.83 PIK3CG (0.76) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL8308378 0.82 MEN1 (1.00) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL8310306 0.82 MEN1 (1.00) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL10518640 0.82 CISD1 (0.73) DNM1NAT1MEN1NPC1ALDH1A1
SCHEMBL10518639 0.82 CISD1 (0.73) DNM1NAT1MEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP claimed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US claimed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US claimed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP claimed
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed